Skip to main content
Premium Trial:

Request an Annual Quote

In Personalized Medicine, So Much Potential -- And So Many Problems

The Wall Street Journal has an article about problems emerging for breast cancer patients as errors in lab tests wipe out whatever benefit was formed by pairing drugs with diagnostics. Therapies like Herceptin, for instance, are prescribed based on test results -- but now, it seems, thousands of patients "may be getting the wrong treatment" because of inaccurate results, the article says. Lee Newcomer, a senior veep at insurance company UnitedHealth Group, is quoted as saying, "We all make the assumption that every test is done well. It turns out it's not a correct assumption."

 

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.